Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
Aimed Bio
★
Aimed Bio Files FDA Phase 1 Clinical Trial Application for BI 4060107 in Solid Tumors... Neutral Impact on Shareholder Value
05/27/2026, 09:24 AM
PERI
Aimed Bio
★★
AimedBio: Tech Transfer Revenue Surges, but R&D Costs Widen Loss
05/15/2026, 02:55 PM
PERI
Aimed Bio
★★
AimedBio Q1 2026: Tech Transfer Revenue Surges, Operating Loss Persists
05/15/2026, 07:30 AM
EXCH
Aimed Bio
★★
Receipt of R&D Milestone Payment from ODS025 Technology Transfer Agreement (Min. ~4.73B KRW)
05/06/2026, 06:11 PM